Related Experiment Videos
Bone gap healing in the dog using recombinant human bone morphogenetic protein-2
1Department of Oral and Maxillofacial Surgery, LSU School of Dentistry, New Orleans, LA 70119-2799, USA. mblock@lsusd.lsumc.edu
Summary
Recombinant human bone morphogenetic protein-2 (rhBMP-2) effectively healed zygomatic arch bone gaps in dogs. rhBMP-2 promoted significant bone formation and maintained arch stability, unlike control sites.
Area of Science:
- Regenerative Medicine
- Oral and Maxillofacial Surgery
- Biomaterials Science
Background:
- Zygomatic arch defects pose challenges for bone regeneration.
- Recombinant human bone morphogenetic protein-2 (rhBMP-2) is a promising osteoinductive agent.
Purpose of the Study:
- To evaluate rhBMP-2 efficacy in healing critical-sized zygomatic arch bone gaps.
- To assess bone formation and structural integrity in a canine model.
Main Methods:
- Zygomatic arch osteotomies were created in 6 dogs, with defects treated with rhBMP-2 in an absorbable collagen sponge (ACS) or buffer/ACS as control.
- Radiographs were taken postoperatively and every 4 weeks for 12 weeks.
- Palpation assessed tissue consistency and arch stability.
Main Results:
- rhBMP-2 treated sites demonstrated significant bone formation by 4 weeks, with increasing radiopacity over time.
- All rhBMP-2 treated arches maintained lateral repositioning and healed, with some showing moderate to excessive bone growth.
- Control sites showed minimal to no bone formation, and 5 out of 6 experienced arch collapse.
Conclusions:
- rhBMP-2 significantly enhances bone gap healing in the craniofacial complex.
- rhBMP-2 promotes osteogenesis and maintains structural stability in zygomatic arch defects.
- This study supports the potential clinical application of rhBMP-2 for craniofacial bone reconstruction.